MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
暂无分享,去创建一个
M. Fabbri | P. Neviani | S. Carloni | F. Foca | M. Murtadha | F. Fabbri | I. Vannini | E. Bandini | Petra M Wise | F. Fanini | Meropi Plousiou